HNF, the Hereditary Neuropathy Foundation, conduct meeting for FDA to advance therapies for Charcot-Marie-Tooth
True Reply was a major fixture of the study and presentation to the FDA capturing the voice and emotion of patients living with Charcot-Marie-Tooth.
Read More: BioSpace
HNF, the Hereditary Neuropathy Foundation, partnered with the True Reply to record patient responses to a five-question survey in their own voice. A total of 621 responses were recorded by the over 100 participants over a 30-day period.
Read More: HNPP Wellbeing
Neurology Reviews® and NORD Publish the 2018 Rare Neurological Disease Special Report
In the largest special edition report to date, True Reply is featured in a special report on the study of pain.
Read More: National Organization for Rare Disorders
Get The Report: Download
World Tokenomic Forum Announces the Final 16 Teams Competing in Grand Cayman May 8-10th at its Sandcastle Startups Challenge 2018
The True Reply team was humbled and honored to be chosen out of so many innovative companies. We were also honored to make it to the final four of the challenge!
Read More: PR Newswire
Tech Company Pledges Up to $200K from Cryptocurrency Sale to Support CMT Disease Research
True Reply committed to donating up to $200,000 from its cryptocurrency sale to support the Hereditary Neuropathy Foundation (HNF) and the Charcot-Marie-Tooth (CMT) disease community.
Read More: Charcot-Marie-Tooth News